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Anticancer and Antioxidant Effects of  
Tragopogon porrifolius extract 
 
Clara A. Tenkerian 
 
ABSTRACT 
 
 
In recent years, the medicinal properties of plant-derived products have come under extensive 
investigation, and plants with antioxidant properties are considered as potential therapeutic 
tools against cancer and other diseases. This study investigates the antioxidant activity of 
Tragopogon porrifolius methanolic extract, both in vitro and in vivo; as well as assessing its effects 
on CCl4-induced hepatotoxicity in rats. It also explores the antiproliferative activity of this 
extract against breast (MDA) and colorectal (CaCo-2) adenocarcinoma cell lines. Total 
phenolic and flavonoid contents were calculated using the Folin-Ciocalteu and the aluminum 
chloride colorimetric methods and found to be 36.96 ± 1.39 mg GAE/g and 16.56 ± 0.42 mg 
QE/g dry weight respectively. In vitro antioxidant activity, assessed using the FRAP assay, 
was determined to be 659.57 ± 13.77 µmol Fe2+/g of extract. The IC50 using the DPPH assay 
was calculated to be 15.18 µg/mL. In rats subjected to CCl4-induced hepatotoxicity, significant 
in vivo antioxidant activity was detected with increased levels of catalase (CAT), superoxide 
dismutase (SOD) and glutathione-S-transferase (GST) liver antioxidant enzymes; the highest 
dose of the extract (250 mg/kg) recorded a fold increase of 1.68 for SOD, 2.49 for GST and 
3.2 for CAT compared to the DMSO vehicle group. The extract also showed substantial 
hepatoprotective capacity by greatly reducing aspartate aminotransferase (AST), alanine 
aminotransferase (ALT) and lactate dehydrogenase (LDH) levels with the 250 mg/kg dose 
recording AST, ALT and LDH levels by 56.89%, 56.45% and 64.65% respectively. Finally, 
measuring the effects of the extract on cell viability and proliferation by the Trypan Blue 
exclusion method and the WST-1 cell proliferation assay both revealed a dose-dependent 
inhibition of cell proliferation and increased cell death. In conclusion, the methanolic extract 
of T. porrifolius showed evidence of antioxidant activity both in vitro and in vivo, as well as an 
anticancer effect against MDA and Caco-2 cell lines. It also exhibited a hepatoprotective 
potential against liver toxicity in rats.  
 
Keywords: Tragopogon porrifolius, Reactive Oxygen Species, Antioxidant, Anticancer, 
Hepatoprotective 
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Chapter 1 
 
INTRODUCTION 
 
1.1 Cancer: 
The American Cancer Society defines cancer as “a group of diseases characterized by 
uncontrolled growth and spread of abnormal cells”. Carcinogenesis is a multistage 
process that often occurs over the sequence of many years (Garcia et al., 2007). Cancer is 
the primary cause of death in developed countries and the second in developing 
countries; and despite extensive research into its causes and potential new treatment 
strategies, cancer remains a leading cause of death globally, after cardiovascular disease 
(Jemal et al., 2011). Moreover, lifestyle changes and an increasingly aging population are 
leading to elevated cancer rates worldwide. Studies indicate that the majority of cancers 
are greatly influenced by environmental factors such as smoking, consumption of alcohol, 
and diet. They are thus attributed more to lifestyle rather than hereditary factors (Anand 
et al., 2008).  
Oncogenesis results from mutations in several genes which can be classified into three 
catagories: proto-oncogenes, tumor-suppressors and stability genes. Proto-oncogenes 
become permanently active and thus oncogenic upon their mutation. Conversely, tumor 
suppressor genes lose their activity when mutated. Given that stability genes regulate 
functions such as DNA repair and chromosomal segregation, mutations in these genes 
lead to higher mutation rate in the genome (Furney, Higgins, Ouzounis, & Lopez-Bigas, 
2006). Futreal et al. conducted a census from the literature to compile a list of “cancer 
genes” or genes in implicated in oncogenesis. At the time of the study, 291 genes had 
been reported in the literature, which constitutes over 1 % of all genes in the human 
genome. Chromosomal translocations were found to be the most common mutation 
class and the protein kinase to be the most common domain among the known cancer 
genes (Futreal et al., 2004).  
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1.1.1 Colorectal cancer: 
Colorectal cancer is one of the most commonly occurring cancers on a global scale and is 
the second major cause of cancer-related deaths in the United States (Center, Jemal, & 
Ward, 2009a; Center, Jemal, Smith, & Ward, 2009b; El Zouhairi, Charabaty, & Pishvaian, 
2011). Among the major risk factors observed are a personal or family history of 
colorectal cancer and/or polyps, chronic inflammatory bowel disease, obesity, heavy 
alcohol consumption, smoking, lack of physical activity and dietary patterns low in fruits 
and vegetables and high in red or processed meat (Center et al., 2009a; Center et al., 
2009b; Garcia et al., 2007). It has been shown to be very responsive to diet modification 
(Gajula et al., 2009). Malnutrition is also common in patients suffering from colorectal 
cancer, effecting their recovery and performance after receiving treatment (Y. Chen et al., 
2011).  
Colorectal cancer is treated most commonly by surgery, which may be curative if the 
cancer has not yet spread. If the tumor has penetrated the bowel wall deeply or spread to 
lymph nodes, patients also receive chemotherapy, sometimes combined with radiation 
(Garcia et al., 2007). 
The Caco-2 cell line, originally derived from a human colon adenocarcinoma, 
differentiates spontaneously in culture to form a monolayer of cells that express many of 
the functional and morphological characteristics of a mature enterocyte and as such can 
be used as an in vitro model for drug absorption and metabolism studies (Hilgers, 
Conradi, & Burton, 1990; Sambuy et al., 2005). Since the initial isolation of the parental 
cell line, several clonal cell lines which do not always express all the same characteristics 
have also been established and used extensively over the past few decades (Sambuy et al., 
2005).  
 
1.1.2 Breast cancer: 
Breast cancer is the most commonly diagnosed cancer in women and its incidence has 
been increasing steadily since the 1940s; it accounts for 23% of the total cancer cases 
3 
 
(Jemal et al., 2011). Despite the decline in the mortality rates of breast cancer, given early 
detection and more advanced therapies, this malignancy remains the leading cause of 
cancer-related death in women, accounting for 14% of all cancer deaths (DeBruin & 
Josephy, 2002; Jemal et al., 2011). The risk factors associated with breast cancer can be 
categorized into three main groups, namely hereditary, hormonal and reproductive, and 
environmental (DeBruin & Josephy, 2002). Inheritance of the BRCA1 or BRCA2 genetic 
mutations, a family history of breast cancer, being overweight and/or the use of 
hormonal therapy after menopause, lack of physical activity and excess alcohol 
consumption are among the most important risk factors associated with breast cancer 
(Garcia et al., 2007). Moreover, a twin cohort study published in the New England 
Journal of Medicine attributed 73% of breast cancer cases to environmental causes 
(Lichtenstein et al. 2000). Nutrition is also hypothesized to be an important 
environmental determinant (Holmes & Willett, 2004).  
Treatment of breast cancer depends on tumor size, stage at diagnosis and other clinical 
characteristics, as well as patient preference. Chemotherapy, radiation and hormone 
therapy are often used in combination with surgical intervention which could be in the 
form of either a lumpectomy (removal of the tumor with clear margins) or a mastectomy 
(removal of the entire breast). The stage of the tumor at diagnosis is the most important 
variable effecting prognosis and survival rate (Garcia et al., 2007). 
The MDA cell line is a human breast adenocarcinoma cell line used as an in vitro model of 
breast carcinoma.  
 
1.2 Reactive Oxygen Species: 
1.2.1 Defining reactive oxygen species: 
Any species capable of existing independently and containing one or more unpaired 
electrons is referred to as a free radical (Halliwell & Gutteridge, 2006). This unpaired 
electron is usually responsible for the high reactivity of the free radical (Valko et al., 2007; 
Miller, Buettner, & Aust, 1990). Oxygen free radicals or reactive oxygen species (ROS), 
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including the superoxide radical O2
•-, hydrogen peroxide H2O2, and the highly reactive 
hydroxyl radical •OH, derive from the metabolic reduction of molecular oxygen and are 
considered important signaling molecules in various pathways involved in the 
proliferation of cells, as well as in the induction of apoptosis (Hasan et al., 2010). 
Although not a free radical itself, H2O2 is involved in the pathway of formation of other 
radicals and hence considered a ROS (Vera-Ramirez et al., 2011; Waris & Ahsan, 2006). 
The ROS are extremely reactive and can oxidize lipids, proteins, and even DNA. 
Increased production of ROS and the resulting oxidative stress have thus been associated 
with the onset and progression of many diseases, including cancer (Hasan et al., 2010).  
 
1.2.2 Physiological and pathological roles of free radicals: 
The mitochondria are the major endogenous source of reactive oxygen species which 
when in equilibrium, play an important role in the regulation of physiological functions. 
Among these useful biological functions are their role in inflammatory responses against 
infectious agents and their involvement in various signaling cascades involved in 
maintaining cellular homeostasis. During inflammation, macrophages and neutrophils 
exhibit increased oxygen consumption and the resulting O2
•- and H2O2 play an important 
role in the first line of defense against pathogens (Valko et al., 2007; Vera-Ramirez et al., 
2011; Manda, Nechifor, & Neagu, 2009; Waris & Ahsan, 2006).   
The Mitogen Activated Protein Kinase (MAPK) family is one of the protein families 
regulating ROS activated signal transduction pathways. The MAPK pathways respond to 
a wide range of stimuli and are involved in the regulation of gene expression, 
proliferation, mitosis, metabolism, mitosis, and apoptosis. Therefore, ROS may lead to 
both proliferation and death of cancer cells, depending on the exogenous and 
endogenous environment (Manda et al., 2009; Waris & Ahsan, 2006). 
However, when the tight regulation maintaining equilibrium between free radicals and the 
antioxidant defense system is compromised, either due to the excess production of ROS 
or the down-regulation of antioxidants, it results in oxidative stress which has been 
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shown to be involved in the initiation and progression of various human diseases, 
including cancer (Evans, Dizdaroglu, & Cooke, 2004; Waris & Ahsan, 2006).  
 
1.2.3 Free radicals and cancer: 
DNA damage induced by free radicals is well documented and widely accepted as a major 
cause of genomic instability and cancer. Human studies have shown that oxidative DNA 
damage is an important carcinogenic and mutagenic factor in the sense that it favors the 
acquisition of mutations and contributes to cellular transformation and cancer cell 
survival (Waris & Ahsan, 2006). 
Oxidative lesions are induced in the genetic material by both exogenous and endogenous 
free radicals; if not efficiently repaired, these will lead to mutations and the subsequent 
deleterious effects. For instance, the hydroxyl radical tends to interact with double bonds 
of DNA bases generating modified bases, DNA strand breaks and aberrant DNA-protein 
interactions (Valko, Izakovic, Mazur, Rhodes, & Telser, 2004; Vera-Ramirez et al., 2011). 
The formation of 8-hydroxy-2‟-deoxyguanosine (8-OH-dG) adducts, which induce errors 
in the reading frame during replication, is one of the well-known consequences of DNA 
exposure to OH•. The damage in the deoxyribose molecules also interferes in the activity 
of DNA polymerase and DNA ligase enzymes. Such modifications have been detected in 
oncogenes and tumor suppressor genes, and it is assumed that reactive oxygen species are 
involved in both the initiation and the progression of cancer (Vera-Ramirez et al., 2011; 
Waris & Ahsan, 2006). 
Elevated levels of 8-OH-dG adducts are reported to play a role both in breast cancer 
(Malins & Haimanot, 1991) and in hepatocellular carcinoma (Ichiba et al., 2003). Lungs 
from cigarette smokers also have a two to three fold elevation in 8-OH-dG (Olinski et al., 
1992).  
In addition, levels of the antioxidant enzymes superoxide dismutase (SOD), glutathione-
S-transferase (GST) and glutathione peroxidase (GPx) were reported to be elevated in 
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colorectal cancer tissues (Kanbagli et al., 2000). SOD and GPx levels have been found to 
be elevated in breast cancer tissue as well (Punnonen et al., 1994).  
 
1.3 The Oxidative balance: 
1.3.1 The antioxidant defense system: 
Exposure to higher than normal concentrations of oxygen has deleterious consequences 
in all aerobes and although ROS exist in all aerobic cells, they are normally in a balance 
with antioxidants which help maintain lower levels of free radicals, thus allowing them to 
perform their beneficial physiological roles (Halliwell & Gutteridge, 2006; Waris & 
Ahsan, 2006).   
Antioxidants are a class of plant secondary metabolites that improve the body‟s cellular 
defense system against oxidative damage. Although synthetic antioxidants such as 
butylated hydroxytoluene (BHT) are available, most lead to toxic side effects like liver 
damage and mutagenesis. Consequently, there has been an increased interest in the search 
for natural antioxidants in recent years. Numerous studies have reported that the intake 
of fruits and vegetables, which have been shown to be rich in antioxidants, plays an 
important role in the prohibition of free radical-associated diseases and decreases the 
incidence of heart disease and cancer in humans. These beneficial effects of plants have 
been ascribed to the polyphenolic compounds they contain (El-Far & Taie, 2009; Sahgal 
et al., 2009; Winkler, Wirleitner, Schroecksnadel, Schennach, & Fuchs, 2005).  
The antioxidant defense system of the body can be in the form of low molecular weight 
antioxidants such as Vitamins E and C which block free radicals, or in the form of 
enzymes such as superoxide dismutase, catalase, and the glutathione system (glutathione, 
glutathione reductase, peroxidase and transferase) that constrain the levels of reactive 
oxygen species (Evans et al., 2004; Manda et al., 2009). However, even though this 
system attenuates the harmful effects caused by free radicals, the damage accumulates 
over the years and is implicated in the development of age-related disorders (Vera-
Ramirez et al., 2011).  
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1.3.2 The major antioxidant enzymes: 
As shown in Figure 1.1, maintaining the oxidative balance and preventing oxidative stress 
requires the cooperation of several antioxidant enzymes (Halliwell, 2006). 
Overproduction of the superoxide radical O2
•- is believed by many scientists to be one of 
the major causes of oxygen toxicity (Fridovich, 1995). Superoxide dismutase enzymes 
(SODs) catalyze its dismutation (reaction 1), whereby one is oxidized to form O2 and 
another reduced into H2O2 (Valko et al., 2004).  
   
SODs must thus work simultaneously with other enzymes to remove H2O2, which would 
otherwise undergo the “Fenton reaction” (reaction 2) and produce the very reactive 
hydroxyl radical (Halliwell, 2006).  
 
Catalases and glutathione peroxidases are two enzymes responsible for this function. 
Catalases break down hydrogen peroxide into water and oxygen (reaction 3), whereas 
glutathione peroxidases reduce it to water by coupling it to the oxidation of reduced 
glutathione (GSH) which is a thiol-containing tripeptide (reaction 4). Glutathione 
reductase enzymes eventually convert back the oxidized glutathione (GSSG) formed by 
this reaction to GSH (Rhee, Chae, & Kim, 2005; Halliwell, 2006).  
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It is important to note however that catalases are not abundant in the mitochondria 
where substantial amounts of the superoxide radical are generated; rather they are mostly 
present in peroxisomes where they catalyze the breakdown of H2O2 produced by 
oxidative enzymes (Halliwell & Gutteridge, 2006; Schrader & Fahimi, 2004).  
 
 
Figure 1.1. Exogenous and endogenous sources of reactive oxygen species and the 
antioxidant defense system. (“Literature review of a cantaloupe melon”, 2007) 
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1.3.3 The importance of superoxide dismutase: 
SOD is the primary enzyme defending an organism against the superoxide anion, and it 
exists in three forms: cytosolic CuZnSOD (coded by the Sod1 gene) which is the 
predominant form responsible for 70-80% of SOD activity, MnSOD (coded by the Sod2 
gene) expressed in the mitochondrial matrix of cells and responsible for 10-20% of SOD 
activity, and extracellular EC-SOD (coded by the Sod3 gene) which is expressed 
selectively in a limited number of tissues. Due to its location, MnSOD is the major 
contributor against reactive oxygen species resulting from mitochondrial respiration 
(Fukui & Zhu, 2010; Van Remmen et al., 2003). 
The importance of this antioxidant enzyme has been reported in many transgenic studies 
over the years. One group reported that mice lacking SOD suffered from extensive 
mitochondrial damage, cardiac abnormalities, and accumulation of fat in the liver and 
skeletal muscles leading to death of the animals within 10 days of their birth. These mice 
also had significant reductions in size and growth rate, unlike the heterozygous mice 
which had similar sizes and growth rates as the wild-type group (Lebovitz et al., 1996). 
Another study showed that although they appear normal at birth, with age SOD 
heterozygous mice exhibited elevated levels of mitochondrial oxidative damage and 
oxidative DNA damage and they developed cancer at an accelerated rate (Van Remmen 
et al., 2003). A third group determined that SOD-knockout mice are less resistant to 
ROS-generating toxins and similar to the previous study, they suffer from an increased 
risk of cancer, liver cancer in particular; as well as neurological damage and hearing loss 
(Elchuri et al., 2005).  
 
1.4 Medicinal usage of plants: 
1.4.1 Transition from traditional to modern medicine: 
Ethnobotanic medicine is broadly defined as the utilization of plants for medicinal uses 
(Fabricant & Farnswort, 2001). Throughout history, plants have always been used as 
medicinal products. Having served as the primary sources of treatment for numerous 
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human diseases for centuries, they continue to be utilized as therapeutic and preventive 
agents in traditional, alternative and even modern medicine, where over 25% of 
prescribed drugs used today include plant-derived constituents (Ma et al., 2005; X.H. 
Chen et al., 2011). Moreover, according to the World Health Organization, 80 % of the 
population of developing countries in Asia and Africa rely on traditional medicine for 
primary health care (World Health Organization [WHO], 2009).  
Currently, the term traditional medicine is used to describe any non-Western medical 
practice. Resorting to traditional medicine in order to discover plants with therapeutic 
properties has proven valuable in the search for new bioactive compounds. 
Ethnopharmacology refers to the observation, description, experimental investigation, 
and determination of biological activities of indigenous drugs as an approach to drug 
discovery (Fabricant & Farnswort, 2001). 
For the past few decades, the advances made in the fields of cell and molecular biology 
have allowed shorter drug discovery timelines by simultaneous testing of a larger number 
of molecular targets. On the other hand, the fact that some natural compounds are 
available only in small quantities, combined with the prolonged lag between the initiation 
of research on a potential therapeutic agent and its actual launch into the market have 
reduced the emphasis of the pharmaceutical companies on natural products (Koehn & 
Carter, 2005; Paterson & Anderson, 2005). In recent years however, concerns over 
harmful side-effects of synthetic compounds have shifted the focus back to natural plant 
resources which represent an abundant source of biologically active molecules (Ma et al., 
2005; Palombo, 2011).  
 
 1.4.2 Medicinal plants in the literature: 
A vast number of reports have been published dealing with the potential use of plants 
against microbial and fungal infections, several disease conditions and even cancer (Cragg 
& Newman, 2005; Kalemba & Kunicka, 2003; Willcox, Bodeker, & Rasoanaivo, 2004). 
During the last few decades, numerous plant extracts and their essential oils have been 
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investigated for their antimicrobial effects and dozens of herbs and spices have been 
found to which various species of bacteria and fungi are susceptible (Kalemba & 
Kunicka, 2003). In addition, over a thousand plants, either as crude extracts, isolated 
active components or as a combination of several plants, were found to be used in 
traditional medicine for the treatment of malaria, a parasitic disease (Willcox et al., 2004).  
Plant-derived compounds have shown effectiveness in non-infectious diseases as well.  
For instance, Kizelsztein, Komanytsky, and Raskin (2009) reported that treatment of 
experimental autoimmune encephalomyelitis (EAE) mice with a molecule isolated from 
Tripterygium wilfordii, a twining vine, resulted in a delay of multiple sclerosis (MS) onset, a 
reduction in relapse rate, and a decrease in demyelination of CNS tissue.  
 
1.4.3 Plant-derived anticancer agents in clinical use: 
Active constituents derived from plants have been used to treat cancer for years and the 
search for chemotherapeutic agents that are efficient against malignant cells, but non-
toxic in non-tumor cells is a major line of research (Jimenez-Medina et al., 2006).  
There are currently four classes of plant-derived anticancer agents in clinical use around 
the world: the vinca alkaloids, the podophyllotoxins, the taxanes, and the camptothecin 
derivatives (Cragg & Newman, 2005).  
The vinca alkaloids, vinblastine (VLB) and vincristine (VCR), were the first plant-derived 
anti-cancer agents discovered and developed in the 1950s. They were obtained from the 
Madagascar periwinkle, Catharanthus roseus, which was traditionally used by many cultures 
for the treatment of diabetes. These compounds, as well as two other active alkaloids 
namely vinleurosine and vinrosidine, were being studied as potential hypoglycemic agents 
when investigators observed reductions in the levels of white blood cells and suppression 
in the bone marrows of rats. Further investigations led to the discovery that the extracts 
were active against lymphocyte leukemia in mice. VLB and VCR were isolated as the 
active compounds and after selective modifications two semi-synthetic agents, 
vinorelbine (VRLB) and vindesine (VDS), were developed and are currently used for the 
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treatment of different types of cancer, such as Kaposi‟s sarcoma, breast, lung and 
advanced testicular cancers, leukemias and lymphomas (Cragg & Newman, 2005; 
Newman, Cragg, & Snader, 2000). The vinca alkaloids function by binding to β-tubulin 
near the GTP-binding site and inhibiting microtubule dynamics. And despite the fact that 
the structures of the various vinca alkaloids vary only slightly, they have distinct niches as 
chemotherapeutic agents and are therefore used in the treatment of different types of 
cancers (Amin, Gali-Muhtasib, Ocker, & Schneider-Stock, 2009).  
Podophyllum peltatum, commonly referred to as the American mandrake or Mayapple, and 
Podophyllum emodii have been used historically to treat skin cancers and warts (Cragg & 
Newman, 2005). They were also used hundreds of years ago by natives of the Himalayan 
mountain area and by American Indians as a cathartic and an anthelmintic (Wang & Lee, 
1997). Although podophyllotoxin, the major bioactive agent, was first isolated as early as 
in 1880, it was only in the 1950s that scientists identified its correct structure. Other 
similar podophyllotoxin-like molecules were also isolated and used in clinical trials; 
however, due to insufficient efficacy and high toxicity reports they were discarded. After 
further studies, etoposide and teniposide, two semi-synthetic derivatives of 
epipodophyllotoxin (an isomer of podophyllotoxin), were found to be clinically active 
and are now used to treat lymphomas and testicular cancer. Etoposide is also extremely 
active against small cell lung carcinoma (Cragg & Newman, 2005; Mans, Da Rocha, & 
Schwartsmann, 2000). Etiposide and teniposide act as inhibitors of topoisomerase II 
(Wang & Lee, 1997). 
The taxanes are a more recent group of chemotherapeutic drugs. Isolated from the bark 
of the Pacific yew, Taxus brevifolia, paclitaxel (Taxol®) is used as an anti-cancer drug 
against ovarian cancer, breast cancer and non-small cell lung cancer. It is also used in the 
treatment of some forms of Kaposi‟s sarcoma. T. brevifolia and other Taxus species were 
traditionally used by Native American tribes to treat several conditions excluding cancer. 
There was even one reported use of Taxus baccata leaves for cancer treatment in 
traditional Asiatic Indian medicine. Additionally, numerous other taxanes are currently in 
preclinical trials for the development of novel chemotherapeutic drugs. Docetaxel 
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(Taxotere®), an active semi-synthetic analog of paclitaxel, provides a major, renewable 
source of this important class of drugs (Cragg & Newman, 2005). Along with the vinca 
alkaloids, the taxanes represent another major class of antimitotic drugs. Taxanes are 
microtubule-targeting agents that bind to polymeric tubulin, stabilizing it and inhibiting 
its disassembly, and thus inhibit cell replication by disrupting normal mitiotic spindle 
formation and ultimately lead to cell death by apoptosis (Amin et al., 2009; Wang & Lee, 
1997). 
The latest additions to the classes of plant-derived anti-cancer drugs are the clinically 
active compounds obtained from camptothecin which was isolated from Camptotheca 
acuminate, a Chinese ornamental tree. Camptothecin first reached the clinical trial stage in 
the 1970s, but due to severe issues of bladder toxicity it was dropped. It eventually came 
back in modified forms called topotecan and irinotecan, gaining approval in the USA in 
1996. These are used for the treatment of ovarian and small cell lung cancers, and for 
colorectal cancers respectively (Cragg & Newman, 2005; Newman et al., 2000). 
Camptothecin and its analogues function as inhibitors of DNA Topoisomerase I (Wang 
& Lee, 1997). Their potency as cytotoxic agents has been verified by various studies to be 
related directly to their ability to inhibit topoisomerase I catalytic activity (Hertzberg et 
al., 1989; Jaxel, Kohn, Wani, Wall, & Pommier, 1989; Kingsbury et al., 1991).  
 
1.5 Tragopogon porrifolius: 
Taking into consideration that of the estimated 500,000 plant species on Earth, only 
about 1% have been investigated for their medicinal qualities, the potential for the 
discovery of novel bioactive compounds is substantial (Palombo, 2011).  
Tragopogon porrifolius, which belongs to the family Asteraceae, is subdivided into three 
subspecies, namely T.porrifolius subsp. australis, T.porrifolius subsp. cupani and T.porrifolius 
subsp porrifolius, only the latter of which is edible (Zidorn et al., 2005). 
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T. porrifolius subspecies porrifolius, more commonly referred to as white salsify, is an annual 
or biennial herb indigenous to Central and Eastern Mediterranean, as well as Asia Minor. 
It has also gained the alternate name “goat‟s beard” due to the appearance of its foliage 
and that of “vegetable oyster” due to the taste of its roots. Ranging in height from 30 to 
125 cm, it has lilac to reddish-purple ligules and its long, grass-like narrow leaves form a 
daisy-like rosette (Figure 1.2). 
 
 
Figure 1.2. Tragopogon porrifolius (Spooner, 1997). 
 
Although its usage as a vegetable has decreased in Southern and Central Europe in recent 
years, it is still popular in the United Kingdom. It is grown for its long, tapering and 
frequently branched roots which are used for flavoring. Its roots, leafy shoots and open 
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flowers are used both cooked or as a raw salad (Gupta, Talwar, V. Jain, Dhawan, & S. 
Jain, 2003). 
As to the use of T. porrifolius as a potential source of bioactive compounds against cancer 
or other free radical associated diseases, studies are thus far very limited. One group 
reported the isolation of phenolic acids and flavonoids which are plant secondary 
metabolites associated with antioxidant activity (Sareedenchai, Ganzera, Ellmerer, 
Lohwasser, & Zidorn, 2009). In another study, it was reported that two out of six 
compounds isolated from T. porrifolius had moderate radical scavenging activity measured 
by the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay (Zidorn et al., 2005). T. porrifolius is 
also used to treat cancer in Lebanese folk medicine. 
The present study investigates the methanolic extract of Tragopogon porrifoilus, a 
biennial wildflower native to Mediterranean regions, as a potential chemotherapeutic 
agent. Total phenolic and flavonoid contents, higher contents of which are correlated 
with increased antioxidant activity and potentially protective roles for human health, are 
assessed. Antioxidant activity is assessed both in vitro through the Ferric Reducing 
Antioxidant Power (FRAP) and the DPPH radical scavenging assays, and in vivo through 
the calculation of catalase (CAT), superoxide dismutase (SOD), and glutathione-S-
transferase (GST) hepatic antioxidant enzymes levels. In addition, the in vivo 
experimentation examines the hepatoprotective effects of the T. porrifolius methanolic 
extract by calculating the levels of aspartate aminotransferase (AST), alanine 
aminotransferase (ALT) and lactate dehydrogenase (LDH) marker enzymes.  Finally, the 
cytotoxicity, the anti-proliferative activity, and the pro-apoptotic effects of this extract 
against colon (Caco-2) and breast (MDA) cell lines are also evaluated.  
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Chapter 2 
 
MATERIALS & METHODS 
 
2.1 Plant material and extraction in methanol: 
The Tragopogon porrifolius plant material was collected from Lebanon and air dried in shade. 
The dried plants were then cut to small pieces and 300 grams were soaked for 72 hours in 
methanol and then filtered. This process was repeated twice to ensure maximal extraction. 
Finally, the solvent was distilled off under reduced pressure using a rotary evaporator and 
the residue was refrigerated for further use. 
 
2.2 Determination of total phenolic and flavonoid contents: 
2.2.1 Determination of total phenolic content: 
Total phenolic content was estimated by the Folin–Ciocalteu colorimetric method, using 
gallic acid (100-1000 mg/L in 80% methanol) as a standard (Tawaha, Alali, Gharaibeh, 
Mohammad, & El-Elimat, 2007). This assay is based on the chemical reduction of the 
Folin–Ciocalteu reagent, a metal oxide mixture of tungsten and molybdenum. Upon 
reduction, a blue color with maximum absorption at 765 nm is produced, whereby the 
intensity of light at this wavelength is proportional to the concentration of phenols in the 
tested sample (Waterhouse, 2002).  
Briefly, 50 µL of the 1:5 diluted and filtered extract (at an original concentration of 100 
mg/mL in methanol) was mixed with 450 µL of distilled water and 2.5 mL of 0.2 N 
Folin–Ciocalteu reagent. After 5 min, 2 ml of saturated sodium carbonate (75 g/L) were 
added and the mixture was incubated at 30 °C for 90 minutes with intermittent shaking. 
The absorbance of the resulting blue-colored solution was measured at 765 nm and the 
total phenolic content was expressed as gallic acid equivalents mg(GAE)/g of dry weight. 
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2.2.2 Determination of total flavonoid content: 
Total ﬂavonoid content was determined by the aluminum chloride colorimetric method, 
using quercetin (10-100 mg/L) as a standard (Lin & Tang, 2007). The principle of this 
technique is the formation of complexes between AlCl3 and the keto or hydroxyl groups 
of flavones, flavonols, and flavonoids (Chang, Yang, Wen, & Chern, 2002).  
Brieﬂy, 500 µL of the 1:20 diluted and filtered extract (at an original concentration of 100 
mg/mL in methanol)  was mixed with 1.5 ml of 95% methanol, 100 µl of 10% aluminum 
chloride (AlCl3), 100 µl of 1 M potassium acetate (CH3COOK), and 2.8 ml of deionized 
water. The mixture was incubated at room temperature for 40 minutes and the absorbance 
was measured at 415 nm. The data were expressed as milligram quercetin equivalents 
(QE)/g lyophilized powder. The total flavonoid content was expressed as quercetin 
equivalents mg (QE)/g dry weight.  
 
 
2.3 Cell lines and cell culture: 
MDA (human breast adenocarcinoma) and Caco-2 (human colorectal adenocarcinoma) 
cell lines were used in the in vitro experiments of cytotoxicity and proliferation.  
Both cell lines were maintained in Dulbecco‟s modified Eagle‟s medium (DMEM) 
supplemented with 10% heat-inactivated fetal bovine serum (FBS), 100 µg/mL 
streptomycin and 100 U/mL penicillin. Cells were incubated at 37 °C in a humidified 
atmosphere of 5% CO2.  
 
2.4 Cytotoxicity assay: 
Cytotoxicity of the T. porrifolius methanolic extract on the cell lines was assayed at 24 and 
48 hours using the Trypan Blue exclusion method, a technique measuring cell viability.   
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Cells were seeded into 24 well plates and a dose/response curve was generated using five 
different concentrations of the crude extract dissolved in DMSO (5, 10, 25, 50, and 100 
µg/mL). After the specified time periods following treatment, the cells were trypsinized, 
diluted in 0.4% Trypan Blue and counted in a hemocytometer chamber. While viable cells 
exclude the dye, the dead cells are stained blue. Cell viability was determined and used to 
plot a dose-response curve and derive the cytotoxic concentration IC50, the concentration 
causing a 50 % decrease in cell viability. All experiments were plated in triplicate wells and 
were performed three times.  
 
 
2.5 Proliferation assay: 
The effect of the T. porrifolius methanolic extract on proliferation of the cell lines was 
measured at 24 and 48 hours using the cell proliferation reagent WST-1, a tetrazolium salt 
which is cleaved by mitochondrial dehydrogenases in metabolically active cells.  
Cells were seeded into 96 well microplates at a density of 1 x 105 cells/well and treated 
with different concentrations of the extract (5, 10, 25, 50, and 100 µg/mL). At the end of 
the treatment period, 10 µL of the cell proliferation reagent WST-1 was added to the cells 
already cultured in 100 µL/well (1:10 final dilution). After 2 hours of incubation in a 
humidified atmosphere (37 °C, 5% CO2), the absorbance of the samples was measured in 
an ELISA microplate reader at 450 nm. All experiments were plated in triplicate wells and 
were performed three times.  
 
2.6 Determination of in vitro antioxidant activity: 
The in vitro antioxidant activity of the T. porrifolius methanolic extract was measured using 
the Ferric Reducing/ Antioxidant Power (FRAP) and the DPPH (2, 2-diphenyl-1-
picrylhydrazyl) free radical scavenging activity assays. 
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2.6.1 The FRAP assay: 
The FRAP assay measures the change in absorbance due to the reduction of the colorless 
Fe3+ by the action of electron donating antioxidants and the formation of Fe2+-
tripyridyltriazine compound which is blue in color. The FRAP value was calculated based 
on the method of Benzie and Strain (1996), using ferrous sulphate (10-100 mM 
FeSO4.7H2O) as a standard (Griffin, Bhagooli, & Weil, 2006).  
The working FRAP reagent consists of 300 mM acetate buffer (pH 3.6), 10 mM TPTZ 
(2,4,6-tripyridyl-s-triazine) in 40 mM HCl and 20 mM ferric chloride (FeCl3·6H2O) 
solution in a 10:1:1 ratio. 150 μL of the freshly prepared and prewarmed (at 37 °C) FRAP 
reagent was added to each well in a 96 well microplate and after a blank reading, 20 µL of 
the sample was added. The absorbance was measured after 8 minutes in an ELISA 
microplate reader at 600 nm. The initial blank reading for each well was subtracted from 
the final reading to determine the FRAP value (micromol ferric ions reduced to ferrous 
form per gram) of each sample.  
 
2.6.2. The DPPH assay: 
The DPPH assay is based on the ability of this stable radical to react with hydrogen 
donors (Chu, Y.W. Lim, Radhakrishnan, & P.E. Lim, 2010). A solution of DPPH, 
originally deep violet, is decolorized to light yellow after reduction with an antioxidant. 
The degree of reduction in absorbance reflects the radical scavenging power of the tested 
compound (Agbafor & Nwachukwu, 2011). 
Briefly, 50 µL of the extract and 50 µL of 0.5 mM DPPH in ethanol were added to each 
well in a 96 well microplate. After incubation in the dark for 40 minutes, the absorbance 
was read at 492 nm. Ascorbic acid and Trolox were used as reference compounds and the 
radical scavenging activity was calculated as percentage inhibition of absorbance.  
IC50, the concentration needed to reduce the initial absorbance of DPPH radical by 50%, 
was calculated graphically using a calibration curve in the linear range by plotting extract 
concentration versus scavenging effect.  
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2.7 Hepatotoxicity bioassay: 
2.7.1 Animals: 
Male Wistar rats weighing 180-220 g were supplied by the Lebanese American University 
animal unit. The animals were housed under stable conditions of temperature (20 ± 2 °C) 
and humidity (50 ±5 %), and an alternating cycle of light and dark.  The animals were 
supplied with standard laboratory rat chow diet and water and were maintained in 
accordance to the appropriate ethical and legal requirements.  
2.7.2 Experimental design: 
Liver damage was induced with CCl4 in a 1:1 (v/v) mixture with olive oil at a dose of 1.5 
mL/kg administered intraperitoneally (Coballase-Urrutia et al., 2011). 
Animals were divided into 9 groups of 6 animals each: 
Group I – normal control (no treatment) 
Groups II and III – extract-treated groups without CCl4 injections (T. porrifolius 
methanolic extract in DMSO, 50 and 250 mg/kg, i.p.) 
Group IV – positive control (olive oil 2 mL/kg + CCl4/olive oil  1.5 mL/kg, i.p) 
Group V – vehicle group (DMSO 2 mL/kg + CCl4/olive oil 1.5 mL/kg, i.p) 
Groups VI, VII and VIII – extract-treated groups (T. porrifolius methanolic extract 
in DMSO, 50, 100 and 250 mg/kg + CCl4/olive oil 1.5 mL/kg, i.p) 
Group IX – only CCl4/olive oil 1.5 mL/kg 
All the groups were treated for 6 consecutive days, in combination with the CCl4 injections 
for the last 3 days of treatment. 48 hours after the administration of the last dose of CCl4 
and the respective treatment of each group (day 8), the animals were anaesthetized with 
diethyl ether and sacrificed. Blood samples were withdrawn from each rat and the liver 
was excised for the determination of antioxidant enzyme levels. 
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2.7.3 Measurement of biochemical parameters:  
The blood collected from each animal was left to clot at room temperature for 45 minutes. 
The serum was then separated by centrifugation at 600g for 15 minutes and used for the 
determination of marker enzymes AST, ALT and LDH. The enzyme levels were assayed 
using commercially available kits (SPINREACT) according to the manufacturer‟s 
instructions.   
Hepatic tissue was homogenized in 0.1 M phosphate buffer (pH 7.0) containing 0.1% 
Triton X-100 with buffer volume being four times the weight of the tissue. The 
homogenate was centrifuged at 19,000g for 10 minutes and the supernatant was used for 
the determination of total protein and the activity of the antioxidant enzymes CAT, SOD 
and GST.  
Total protein concentration was determined using the Bio-Rad Protein Assay Kit II, 
according to the manufacturer‟s instructions and using bovine serum albumin (0.1-1 
mg/mL) to generate the standard curve. 
 
2.7.3.1 CAT assay: 
Catalase activity was assayed on the basis of H2O2 disappearance (Pedraza-Chaverri et 
al., 1999, 2001, 2005). A 5 µL aliquot of the 1:40 diluted supernatant was added to 
720 µL of 30 mM H2O2 in 10 mM potassium phosphate solution. The decomposition 
of H2O2 by CAT contained in the samples was measured at 240 nm for a period of 15 
seconds. The reaction follows a first-order kinetics given by the equation k =2.3/t 
logA0/A where k is the first-order reaction rate constant, t is the time over which the 
decrease of H2O2 was measured, and A0 and A are the optical densities at times 0 and 
15 s respectively. The results were expressed in k/mg protein.  
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2.7.3.2 SOD assay: 
SOD activity was assayed according to the method of Marklund and Marklund (1974) 
as modified by Naskar et al. (2010). 50 µL of the homogenized liver supernatant was 
added to 2.8 mL Tris-EDTA (49.78 mM Tris, 1.2 mM EDTA; pH= 8.5) and 100 µL 
of 2mM pyrogallol. The mixture was scanned for 3 minutes at 420 nm and compared 
to the control which consists only of Tris-EDTA and pyrogallol.  
One unit of SOD is the amount of enzyme that inhibits the rate of auto-oxidation of 
pyrogallol by 50%.  
The results were calculated according to the following equations:  
                   Rate (R) = (A3 – A0)/t   where t = 3  
                   % inhibition= [(Rcontrol –R)/Rcontrol] x 100 
                   Enzyme unit (U) = (%inhibition/50) x dilution factor 
     
2.7.3.3 GST assay: 
GST activity was assayed based on the method of Habig, Pabst and Jakoby (1974) as 
modified by Al-Saffar, Ganabadi, Fakurazi and Yaakub (2011). 600 µL of the 
supernatant was added to 2.2 mL of 0.1 M potassium phosphate buffer (pH 6.5), 100 
µL of 30 mM CDNB (1-chloro-2,4-dinitrobencene) and 100 µL of 30 mM GSH. The 
absorbance was read at 340 nm after 1 minute and the activity of GST was expressed 
in nmol of GSH-CDNB conjugates formed/min/mg protein using an extinction 
coefficient of 9.6 mM-1cm-1.  
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Chapter 3 
 
RESULTS 
 
3.1 Yield of plant material: 
The extraction of Tragopogon porrifollius plant material, using methanol as a solvent, 
generated 27.7 grams of a semi-solid crude extract. The percent yield was 9.23 %. 
 
3.2 Total phenolic and flavonoid contents: 
Total phenolic content of the methanolic extract of T. porrifolius was estimated by the 
Folin–Ciocalteu colorimetric method using gallic acid to generate the standard curve and 
was determined to be 36.95 ± 1.39 mg GAE/g dry weight.  
Total flavonoid content of the methanolic extract of T. porrifolius was estimated by the 
aluminum chloride colorimetric method using quercetin to generate the standard curve 
and was determined to be 16.56 ± 0.42 mg QE/g dry weight.  
 
3.3 Cytotoxicity of T. porrifolius methanolic extract: 
      The cytotoxic effects of T. porrifolius methanolic extract on the MDA and Caco-2 cell lines, 
determined by the Trypan Blue exclusion method, are shown in Figure 3.1 and Figure 3.2 
respectively and demonstrate a decrease in cell viability that is both dose-dependent and 
time dependent. IC50 after 48 hours of exposure to the extract was determined to be 74.29 
µg/mL for the MDA cell line, and 93.00 µg/mL for the Caco-2 cell line.  
      Two tailed t-tests, performed to validate the reductions in cell viability, demonstrated that 
results for the MDA cell line were statistically significant for all concentrations of the 
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extract and for both time periods (P < 0.02), except for the 5 µg/mL concentration at 24 
hours for which P > 0.05. For the Caco-2 cell line however, none were determined to be 
statistically significant (P > 0.05) except for the highest concentration 100 µg/mL  
concentration at 24 hour time period, and the 50 µg/mL and 100 µg/mL concentrations 
at the 48 hour time period (P < 0.05).  
 
3.4 Effect of T. porrifoilius methanolic extract on proliferation: 
The effect of the T. porrifolius methanolic extract on the proliferation of the MDA and 
Caco-2 cell lines was measured using the WST-1 proliferation assay which is based on the 
enzymatic cleavage of the tetrazolium salt WST-1 into formazan by mitochondrial 
dehydrogenases in viable cells. The results, shown in Figure 3.3, demonstrate a dose and 
time dependent decrease in proliferation. Although the IC50 wasn‟t reached, the highest 
concentration used (100 µg/mL) reduced proliferation to 51.86% and 56.26% viability in 
the MDA and Caco-2 cell lines respectively.  
The results were shown to be statistically significant for all of the concentrations tested at 
both 24 and 48 hours when compared to the group that received only DMSO (P < 0.04 
for the Caco-2 cell line and P < 0.05 for the MDA cell line). The only exceptions were the 
5 µg/mL and 25 µg/mL concentrations in the MDA cell line for which P > 0.05.  
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Figure 3.1. Cytotoxicity of T. porrifoilius methanolic extract on MDA cells at 24 and 48 
hours of treatment. (A and B) Effect of the extract on cell viability. (C) Dose 
response curve of the extract.  
The error bars represent the standard error of the means for three independent 
experiments (SEM).  
* P < 0.02 with respect to the group that received only DMSO. 
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Figure 3.2. Cytotoxicity of T. porrifoilius methanolic extract on Caco-2 cells at 24 and 
48 hours of treatment. (A and B) Effect of the extract on cell viability. (C) Dose 
response curve of the extract.  
The error bars represent the standard error of the means for three independent 
experiments (SEM).  
* P < 0.05 with respect to the group that received only DMSO. 
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Figure 3.3. The effect of T. porrifolius on proliferation of MDA (A) and Caco-2 (B) 
cell lines in the presence of increasing concentration of the methanolic extract at 24 
and 48 hours of treatment.  
* P < 0.05 with respect to the group that received only DMSO. 
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3.5 In vitro antioxidant activity:  
The in vitro antioxidant activity of the T. porrifolius methanolic extract was determined by 
two methods: the ferric reducing/antioxidant power (FRAP) assay and the DPPH free 
radical scavenging assay.  
 
3.5.1. The FRAP assay: 
In the FRAP assay, antioxidant activity is measured as the capacity of the tested 
compound to reduce Fe3+-TPTZ complex to Fe2+-TPTZ; a higher reduction corresponds 
to a higher antioxidant activity. The FRAP value of the methanolic extract was calculated 
using ferrous sulphate to generate a standard curve and was determined to be 659.57 ± 
13.77 µmol Fe2+/g. Ascorbic acid and Trolox were used as reference compounds and their 
FRAP values were calculated to be 889.27 ± 17.13 and 1349.86 ± 53.41 µmol Fe2+/g 
respectively. The results are shown in Figure 3.4. 
 
3.5.2 The DPPH assay: 
In the DPPH free radical scavenging assay, antioxidant activity is measured as the capacity 
of the tested compound to reduce the stable DPPH radical. The IC50 value represents the 
concentration needed to cause a 50% inhibition of DPPH•. Different concentrations of 
the extract, as well as ascorbic acid and Trolox, were used and the IC50 values were 
determined to be 15.18 µg/mL for the extract, 9.13 µg/mL for ascorbic acid and 6.82 
µg/mL for Trolox. The results are shown in Figure 3.5. 
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Figure 3.4.  Ferric reducing abilities of T. porrifolius methanolic extract, ascorbic acid, 
and Trolox. Each column represents the mean of 3 experiments and the error bars 
represent the standard error of the means (SEM). 
 
 
Figure 3.5. DPPH radical scavenging activities of T. porrifolius methanolic extract, 
ascorbic acid, and Trolox. Each column represents the mean of 3 experiments and the 
error bars represent the standard error of the means (SEM).  
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3.6 In vivo antioxidant activity: 
The in vivo antioxidant activity of the T. porrifolius methanolic extract was determined by 
the evaluation of catalase, glutathione-S-transferase and superoxide dismutase antioxidant 
enzymes in the livers of both normal and CCl4-treated rats. The increases in the level of 
these enzymes are shown in figures 3.6, 3.7 and 3.8 respectively. 
Enzyme activity observed in the hepatic tissue of CCl4-treated rats was significantly lower 
compared to the normal group. However, in the groups pretreated with the T. porrifolius 
methanolic extract, there was a significant dose-dependent increase in activity when 
compared to the group that received CCl4 alone, and the highest dose (250 mg/kg body 
weight) restored the activity of all three enzymes to normal levels. On the other hand, the 
groups that received only the extract without the CCl4 injections had higher enzyme 
activity compared to the normal group.  
The results of all the groups were shown to be statistically significant (P < 0.02) by a two-
tailed t-test when compared to the normal group, except groups II (50 mg/kg T. porrifolius 
extract only) and VIII (250 mg/kg T. porrifolius extract + CCl4) for which P > 0.05. 
However, the results of group VIII were highly significant (P < 0.001) when compared to 
the vehicle group which received DMSO and CCl4. 
 
3.7 Hepatoprotective activity: 
The animals treated only with T. porrifolius methanolic extract at doses of 50 and 250 
mg/kg body weight exhibited no significant changes in AST, ALT and LDH marker 
enzymes. The slight elevations at the level of these enzymes were found to be statistically 
insignificant (P > 0.05). Furthermore, in the groups subjected to CCl4-induced 
hepatotoxicity, those pretreated with the extract exhibited substantial and significant (P < 
0.05; with the exception of the 50 mg/kg dose for ALT for which P > 0.05) 
hepatoprotective capacity. The three doses (50, 100 and 250 mg/kg) used respectively 
reduced AST levels by 26.90, 40.19 and 51.74 percent, ALT levels by 17.91, 31.84 and 
50.74 percent, and LDH levels by 30.50, 48.81 and 61.18 percent compared to the vehicle 
group that received DMSO and CCl4. The results are shown in figures 3.9, 3.10 and 3.11. 
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Figure 3.6. Effect of the methanolic extract of T. porrifolius (METP) on the activity of 
CAT antioxidant enzyme in vivo. Each column represents the mean of 6 animals and 
the error bars represent the standard error of the means (SEM). 
a  P < 0.05 with respect to the normal group 
b P < 0.001 with respect to the vehicle group (DMSO + CCl4) 
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Figure 3.7. Effect of the methanolic extract of T. porrifolius (METP) on the activity of 
GST antioxidant enzyme in vivo. Each column represents the mean of 6 animals and 
the error bars represent the standard error of the means (SEM).  
a  P < 0.05 with respect to the normal group 
b P < 0.001 with respect to the vehicle group (DMSO + CCl4) 
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Figure 3.8. Effect of the methanolic extract of T. porrifolius (METP) on the activity of 
SOD antioxidant enzyme in vivo. Each column represents the mean of 6 animals and 
the error bars represent the standard error of the means (SEM).  
a  P < 0.05 with respect to the normal group 
b P < 0.001 with respect to the vehicle group (DMSO + CCl4) 
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Figure 3.9. Effect of the methanolic extract of T. porrifolius (METP) on AST enzyme 
levels in serum. Each column represents the mean of 6 animals and the error bars 
represent the standard error of the means (SEM). 
* P < 0.05 with respect to the group that received DMSO and CCl4. 
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Figure 3.10. Effect of the methanolic extract of T. porrifolius (METP) on ALT enzyme 
levels in serum. Each column represents the mean of 6 animals and the error bars 
represent the standard error of the means (SEM). 
* P < 0.05 with respect to the group that received DMSO and CCl4. 
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Figure 3.11. Effect of the methanolic extract of T. porrifolius (METP) on ALT enzyme 
levels in serum. Each column represents the mean of 6 animals and the error bars 
represent the standard error of the means (SEM). 
* P < 0.05 with respect to the group that received DMSO and CCl4. 
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Chapter 4 
 
DISCUSSION & CONCLUSIONS 
 
Reactive oxygen species (ROS) have been associated with many degenerative diseases and are 
considered potential carcinogens. These oxygen-derived free radicals can induce injury to 
nuclear DNA, facilitating mutagenesis and leading to cancer initiation and progression. When 
regulated, ROS act as signal transduction molecules involved in various signaling pathways 
(Ferreira et al., 2010; Manda et al., 2009).  Antioxidants, which can be of endogenous and 
exogenous origin, provide protection to cellular systems from the harmful effects of excessive 
oxidations and consequently contribute to the inhibition of many diseases such as CHD and 
cancer (G.G. Duthie, S.J. Duthie, & Kyle, 2000).  
In this study, the antioxidant and the anticancer effects of the methanolic extract of Tragopogon 
porrifolius were investigated through in vitro studies on breast and colorectal adenocarcinoma 
cell lines, as well as by testing its effects on the levels of hepatic antioxidant enzymes in a rat 
model. 
The results obtained from the in vitro studies on the MDA and Caco-2 cell lines indicate that 
the T. porrifolius methanolic extract exhibits an antiproliferative effect on both cell lines in a 
time and dose-dependent manner. In the WST-1 proliferation assay, the highest dose of the 
extract (100 µg/mL) significantly (P < 0.001) reduced the proliferation of both cell lines by 
approximately 50% after 48 hours of treatment. However, given that this dose is higher than 
the IC50 values calculated by the Trypan Blue exclusion method, which were 74.29 µg/mL for 
the MDA cell line and 93.00 µg/mL for Caco-2 cell line, this reduction in proliferation might 
be due to cytotoxicity of the extract at this dose. Nevertheless, the 50 µg/mL concentration of 
the extract, which is lower than the IC50 calculated for both cell lines, reduced proliferation by 
36% and 42% for the MDA and Caco-2 cell lines respectively.  
38 
 
Studies have shown that cancer cells are usually under increased oxidative stress in 
comparison to normal cells. This is exhibited by the detection of accumulated ROS-mediated 
reaction products in urine or plasma, by elevated ROS production, or by overexpression of 
antioxidant enzymes such as superoxide dismutase, catalase and glutathione-S-transferase as a 
result of the oxidative stress. Given that cancer cells are metabolically more active than normal 
cells, with functions associated with proliferation and uncontrolled cell growth, they demand a 
higher supply of ATP and consequently burden the mitochondrial respiration chain with 
additional stress and lead to greater ROS production. In response, the cell adapts by 
upregulating the expression of antioxidant enzymes in order to protect itself against the 
oxidative stress. Nevertheless, such adaptation mechanisms are limited because cancer cells 
tend to exhaust ROS-buffering capacity (Pelicano, Carney, & Huang, 2004). 
CCl4 is a potent toxin that is used extensively to study ROS-induced liver damage. This model 
is analogous to hepatotoxicity in humans (Ferreira et al., 2010). The results of the in vivo 
studies show a substantial and significant (P <0.001) decrease in the levels of liver antioxidant 
enzymes in group IX, which received only CCl4, relative to group I, which was the untreated 
control group. This result is consistent with many reports in the literature observing the 
hepatotoxicity of CCl4 (Agbafor & Nwachukwu, 2011; Ganie, Haq, Masood, & Zargar, 2010; 
Lima, Suja, Sathyanarayanan, & Remya, 2010). However, the levels of these enzymes were 
reversed in the groups pretreated with the T. porrifolius methanolic extract. In addition, when 
the extract alone was given, without inducing toxicity with CCl4, enzyme levels were higher 
than the normal untreated group (Table 1). These observations reflect an antioxidant activity 
by the extract. 
The aforementioned antioxidant enzymes constitute the first-line defense against oxidative 
stress and damage caused by free radicals (Agbafor & Nwachukwu, 2011). The most 
important effects of T. porrifolius methanolic extract were observed on the levels of catalase. 
The groups that received the extract alone at concentrations of 50 and 250 µg/mL (groups II 
and III) increased the level of this enzyme by 22.56% and 78.15% respectively. In addition, in 
the CCl4- treated groups, the three doses (50, 100 and 250 µg/mL) raised CAT levels by 72, 
124, and 222 percent respectively compared to the vehicle group that received DMSO and 
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CCl4. The extract had a less effectual influence on the levels of superoxide dismutase and 
glutathione-S-transferase enzymes whereby group II increased SOD and GST levels by only 
13 and 16 percent, and group III by 27 and 29 percent. Similarly, in the CCl4- treated groups, 
the three doses (50, 100 and 250 µg/mL) increased SOD levels by 23, 37 and 68 percent 
respectively. As for GST, the lowest dose exhibited no effect on this enzyme and the higher 
two doses lead to a 36 and 149 percent increase compared to the vehicle group.  
Furthermore, the antioxidant capacity of the T. porrifolius extract was also tested by in vitro 
assays. In the Ferric Reducing/Antioxidant Power assay, the extract had a FRAP value of 659 
µmol Fe2+ formed per gram of dry weight which was fairly comparable to that of ascorbic 
acid, 889 Fe2+/g. In an article by Song et al. (2010) reporting the antioxidant capacities of 56 
Chinese medicinal plants, the FRAP values ranged from as low as 0.15 μmol Fe2+/g to 
856.92 μmol Fe2+/g. Based on this assay, T. porrifolius methanolic extract can be considered to 
have a relatively high antioxidant capacity. The second in vitro assay, the DPPH radical 
scavenging assay, also revealed good antioxidant activity comparable to ascorbic acid. The IC50 
of ascorbic acid was determined to be 9.13 µg/mL, which was consistent with Kano, 
Takayanagi, Harada, Makino and Ishikawa (2005). The IC50 of the extract was calculated to be 
15.18 µg/mL.  
Numerous phenolic compounds are produced by plants as secondary metabolites. Among 
their diverse functions, including pollination, pigmentation, and resistance against pathogens 
and predators, polyphenols are also capable of scavenging free radicals by donating a 
hydrogen atom and are thus considered efficient antioxidants in a wide range of oxidation 
systems (Duthie et al., 2000). Total phenolic content of the T. porrifolius methanolic extract was 
calculated to be 36.95 ± 1.39 mg GAE/g dry weight. In the article by Song et al. (2010), the 
total phenolic content of the 56 Chinese medicinal plants ranged from 0.12 to 59.43 mg 
GAE/g. In another study of 51 Jordanian plant species, total phenolic content of the 
methanolic extracts ranged from 2.6 to 59.6 mg GAE/g dry weight, with any value greater 
than 20 mg GAE/g considered to be “remarkably high” (Tawaha et al., 2007). The total 
content of flavonoids, which are considered to have beneficial effects on a variety of diseases, 
including cardiovascular diseases and cancer (Hou & Kumamoto, 2010), was determined to be 
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16.56 ± 0.42 mg QE/g dry weight. In one study of the methanolic extracts of six species of 
edible Irish seaweeds, the total flavonoid content ranged from 7.41 to 42.50 mg QE/g (Cox, 
Abu-Ghannam, & Gupta, 2010). Consequently, the antioxidant activity of the T. porrifolius 
methanolic extract can be attributed to the relatively high levels of phenols and flavonoids.  
Finally, given that any new potential therapeutic agent should not have harmful side-effects on 
health, the effects of the T. porrifolius methanolic extract on liver damage were also assessed. 
Levels of ALT, AST and LDH, marker enzymes released into the bloodstream in the event of 
tissue damage (Lima, Suja, Sathyanarayanan, & Remya, 2010), were used to evaluate hepatic 
damage. The extract itself didn‟t cause significant hepatotoxicity, with only slight elevations in 
AST, ALT and LDH levels. However, in the CCl4-treated groups, all three concentrations of 
the extract (50, 100 and 250 mg/kg) were able to protect the liver from the CCl4-induced 
toxicity by reducing the levels of these enzymes in serum. In a similar study by Jadhav, 
Thakare, Suralkar, Deshpande, and Naik (2010), a concentration of 200 mg/kg of silimarin, 
which is a standard reference drug, reduced AST, ALT and LDH levels at rates very similar to 
the 250 mg/kg dose of T. porrifolius methanolic extract when compared to the group that 
received only CCl4 injections (75.84, 57.33 and 57.57 percent respectively in the case of 
silymarin, compared to 64.63, 56.89 and 56.45 percent in the case of the extract). These 
observations indicate that the methanolic extract of T. porrifolius has a hepatoprotective 
activity. The 100 mg/kg concentration of the extract also showed substantial and significant 
(P < 0.01) antihepatotoxic effects by reducing AST, ALT and LDH levels by 46.57, 39.73 and 
53.36 percent respectively compared to group IX (received only CCl4). 
In conclusion, the Tragopogon porrifolius methanolic extract exhibited anticancer, antioxidant and 
hepatoprotective effects. Its anticancer activity was revealed through in vitro assays on the 
MDA and Caco-2 cell lines, which showed a time and dose-dependent inhibition of cell 
proliferation and increased cell death. Antioxidant activity was demonstrated both in vivo by 
increasing the activities of SOD, CAT and GST antioxidant enzymes in extract-treated groups 
in a rat model, and in vitro by exhibiting high reducing capacity in the FRAP and DPPH assays. 
This antioxidant activity may be attributed to the relatively high contents of total phenols and 
flavonoids determined to be contained in the extract. Lastly, reducing the levels of AST, ALT 
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and LDH marker enzymes in CCl4-treated rats indicated that not only is T. porrifolius non-toxic 
to the liver, but it also provides a protective role against liver toxicity in rats. 
Given that the crude extract was used in these experiments, further studies are needed to 
determine the active component in T. porrifolius and establish its mechanism of action.  
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APPENDIX A 
 
 
Group 
 
CAT 
(k/mg) 
 
GST 
(nmol/min/mg) 
 
SOD 
(units) 
 
I 
 
Normal (no treatment) 
 
4.77 ± 0.54 7.37 ± 0.52  13.44 ± 0.60 
 
II 
 
T. porrifolius 50 mg/kg 
 
5.85 ± 0.81 8.51 ± 0.73  15.25 ± 0.68 
 
III 
 
T. porrifolius 250 mg/kg 
 
8.51 ± 0.54 a 9.54 ± 0.65 a 17.00 ± 0.56 a 
 
IV 
 
olive oil + CCl4 
 
1.07 ± 0.15 a 2.58 ± 0.43 a 9.88 ± 0.35 a 
 
V 
 
DMSO + CCl4 
 
1.43 ± 0.11 a 2.35 ± 0.51 a 8.38 ± 0.52 a 
 
VI 
 
T. porrifolius 50 mg/kg + CCl4 
 
2.46 ± 0.34 a b 1.64 ± 0.16 a 10.32 ± 0.91 a 
 
VII 
 
T. porrifolius 100 mg/kg + CCl4 
 
3.19 ± 0.35 a b 3.19 ± 0.41 a 10.91 ± 0.63 a b 
 
VIII 
 
T. porrifolius 250 mg/kg + CCl4 
 
4.61 ± 0.27 b 5.86 ± 0.65 b 14.11 ± 0.73 b 
 
IX 
 
only CCl4 
 
1.05 ± 0.12 a 0.92 ± 0.13 a 6.33 ± 0.74 a 
 
Table 1. Effect of T. porrifolius methanolic extract on the activities of liver antioxidant 
enzymes. Values are mean ± SEM of 6 animals in each group and evaluated by two-tailed t-
test. P < 0.02 compared to the normal control group (group I) except for groups II and 
VIII for which P > 0.05.  
a  P < 0.05 with respect to the normal group  
b P < 0.001 with respect to the vehicle group (DMSO + CCl4) 
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Group 
 
AST 
(U/L) 
 
ALT 
(U/L) 
 
LDH 
(U/L) 
 
I 
 
Normal (no treatment) 
 
61.83 ± 2.44 33.44 ± 2.63 312.74 ± 53.27 
 
II 
 
T. porrifolius 50 mg/kg 
 
60.67 ± 0.86 35.58 ± 1.20 315.2 ± 16.74 
 
III 
 
T. porrifolius 250 mg/kg 
 
67.81 ± 1.54 38.35 ± 2.45 369.37 ± 27.17 
 
IV 
 
olive oil + CCl4 
 
83.32 ± 4.91 51.72 ± 3.83 565.83 ± 52.77 
 
V 
 
DMSO + CCl4 
 
122.89 ± 14.22 58.62 ± 4.24 727.53 ± 96.12 
 
VI 
 
T. porrifolius 50 mg/kg + CCl4 
 
89.83 ± 8.20 * 48.12 ± 5.71 505.63 ± 62.30 * 
 
VII 
 
T. porrifolius 100 mg/kg + CCl4 
 
73.5 ± 1.86 * 39.96 ± 2.63 * 372.38 ± 28.12 * 
 
VIII 
 
T. porrifolius 250 mg/kg + CCl4 
 
59.30 ± 5.82 * 28.87 ± 5.65 * 282.37 ± 17.97 * 
 
IX 
 
only CCl4 
 
137.57 ± 9.03 66.30 ± 4.10  798.40 ± 53.57 
 
Table 2. Effect of T. porrifolius methanolic extract on the activities of liver function 
enzymes in serum. Values are mean ± SEM of 6 animals in each group and evaluated by 
two-tailed t-test.  
* P < 0.05 with respect to the group that received DMSO and CCl4. 
 
